The objective of the course work component in both the MSc and PhD programs is to ensure that the students have a broad background in pharmacology as a discipline, as well as insight into contemporary research in molecular pharmacology and areas appropriate to their particular research interest.
M.Sc. Program:
The minimum formal requirements are successful completion of a) PMCOL 508 and b) one course from the following list: PMCOL 501, PMCOL 502, PMCOL 503, PMCOL 504, PMCOL 505, PMCOL 512, PMCOL 514, PMCOL 515, PMCOL 525. Substitution of other graduate-level courses is considered on individual basis.
Ph.D. Program:
The minimum formal requirements are successful completion of a) PMCOL 508 and b) two courses from the following list: PMCOL 501, PMCOL 502, PMCOL 503, PMCOL 504, PMCOL 505, PMCOL 512, PMCOL 514, PMCOL 515, PMCOL 525. Substitution of other graduate-level courses is considered on individual basis. Courses completed while students are registered for the MSc degree may be credited towards meeting the requirements of the PhD program of those students who transfer.
M.Sc. Program:
Each student is expected to perform original research work under the direction of his/her supervisor(s), and the guidance of a Supervisory Committee. The work should be of significance and quality acceptable for publication in refereed scientific journals. A thesis shall be prepared, presented and defended in accordance with FGSR regulations.
Ph.D. Program:
Students admitted to the PhD program are expected to engage in original research that creates significant new knowledge, and is of quality acceptable for publication in refereed scientific journals. Students must submit for acceptance a thesis proposal that outlines the intended course of their studies. University regulations require students of the PhD program to pass an oral candidacy examination, normally within two years of commencement of program. A thesis shall be prepared, presented and defended in accordance with FGSR regulations.